DekaBank Deutsche Girozentrale increased its stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 0.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 178,876 shares of the insurance provider’s stock after purchasing an additional 312 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Allstate were worth $34,941,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in ALL. Arlington Trust Co LLC grew its holdings in shares of Allstate by 261.8% during the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after buying an additional 89 shares in the last quarter. Hughes Financial Services LLC acquired a new stake in Allstate during the first quarter worth approximately $28,000. Hilltop National Bank acquired a new stake in Allstate during the second quarter worth approximately $34,000. Meeder Asset Management Inc. grew its stake in Allstate by 113.8% in the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 99 shares during the period. Finally, McClarren Financial Advisors Inc. acquired a new position in Allstate in the 1st quarter valued at $43,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the company. Citigroup upgraded Allstate to a “hold” rating in a report on Wednesday, August 13th. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a research note on Wednesday, October 8th. BMO Capital Markets lifted their price target on Allstate from $230.00 to $235.00 and gave the company an “outperform” rating in a report on Wednesday, August 20th. Wolfe Research upgraded shares of Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Finally, Barclays reissued an “underweight” rating and issued a $198.00 target price (up from $188.00) on shares of Allstate in a research report on Thursday, July 31st. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $234.60.
Allstate Stock Performance
Allstate stock opened at $193.79 on Wednesday. The company has a market cap of $51.06 billion, a price-to-earnings ratio of 9.11, a price-to-earnings-growth ratio of 0.71 and a beta of 0.38. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The stock’s 50-day moving average is $205.11 and its 200-day moving average is $200.84.
Allstate (NYSE:ALL – Get Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.20 by $2.74. The business had revenue of $15.05 billion during the quarter, compared to analysts’ expectations of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.61 EPS. Equities analysts anticipate that The Allstate Corporation will post 18.74 earnings per share for the current year.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- ETF Screener: Uses and Step-by-Step Guide
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
